prostate cancer

See the following -

Atrazine: Syngenta's Herbicide Doesn't Just Poison Frogs - It Could Give You Cancer

F William Engdahl | Ecologist | June 2, 2014

Tyrone Hayes has fought a 15-year battle with Syngenta following his discovery that its herbicide Atrazine scrambles sex in frogs, writes F William Engdahl. Now he wants to know - is Atrazine the cause of the US's 2-fold reproductive cancer excess among Blacks and Hispanics?...

Read More »

Big Pharma Companies Open Up Cancer Trial Comparator Arm Data

Nick Paul Taylor | Fierce Biotech IT | April 11, 2014

A lot has changed in clinical trial transparency since Project Data Sphere outlined plans to share cancer results in 2012, with the European law voted in last week then still a distant threat. Even so, Pfizer ($PFE), Sanofi ($SNY) and the other groups behind the initiative think it still offers something different now that it has belatedly launched.

Read More »

Crowdsourcing a Better Prostate Cancer Prediction Tool

Press Release | University of Colorado Anschutz Medical Campus | November 15, 2016

Knowing the likely course of cancer can influence treatment decisions. Now a new prediction model published today in Lancet Oncology offers a more accurate prognosis for a patient's metastatic castration-resistant prostate cancer. The approach was as novel as the result - while researchers commonly work in small groups, intentionally isolating their data, the current study embraces the call in Joe Biden's "Cancer Moonshot" to open their question and their data, collecting previously published clinical trial data and calling for worldwide collaboration to evaluate its predictive power...

Read More »

Lack of Vitamin D May Be Key To Why Black Men Get More Deadly Prostate Cancers

Nick Stockton | Quartz | May 4, 2014

It’s well established that black men are more than twice as likely to die from prostate cancer as white men. A new study (paywall) suggests that differences in the way African-Americans process vitamin D could explain some of these worse outcomes...

Read More »

Telemedicine in Clinical Trials Highlighted At Upcoming Conferences

Press Release | AMC Health | September 9, 2014

...At the Mobile and Clinical Trials Conference on September 10 and the  4th annual Dpharm: Disruptive Innovations in Clinical Trials Conference September 11-12, panelists will describe how telemedicine technology from AMC Health, a pioneer in providing telemedicine solutions for clinical trials, is being used to overcome these limitations...

Read More »

Winners Announced for Crowdsourcing and Data Sharing Competition to Drive Innovation in Prostate Cancer Research

Press Release | Sage Bionetworks, Project Data Sphere Initiative, DREAM Challenges Initiative | August 27, 2015

Industry leaders in biomedical research, oncology data sharing and computational science announced the winners of an innovative research challenge for prostate cancer using previously unavailable clinical data. The Prostate Cancer DREAM Challenge is the first research challenge in prostate cancer to marry crowdsourcing with data sharing, paving a new way to tackle key research questions about metastatic castration-resistant prostate cancer (mCRPC), an advanced form of the disease with poor outcomes. The Challenge called upon the cancer research and computational biology community to find solutions to key open clinical research questions about mCRPC and explore innovative research and modeling approaches. The three specific questions posed were to: